Public trial registry of the CCC-Munich

Trial PCNSL

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
PCNSL
World
Full title
:

Temsirolimus bei PZNSL

World
Description
:

Therapy and pharmacokinetic study of temsirolimus in
refractory or relapsed primary CNS lymphoma
(PZNSL)

Therapie- und Pharmakokinetikstudie von Temsirolimus bei
refraktärem oder rezidiviertem primärem ZNS Lymphom
(PZNSL)

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Medizinische Klinik III, Telefon: 089440072551
Indications
Classification Code Description
ICD-10-GM C85.9 Non-Hodgkin-Lymphom, nicht näher bezeichnet
- CNS Tumors
- Bloodcancer (leukemia, lymphoma)
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
II
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2014-06-30 / Unknown
Therapy
World
Therapy line
:
1
Participants
Function Prename Surname Organization
World Principal Investigator MARTIN DREYLING Keine Organisationseinheit angegeben Magnifier
World Responsible contact Carmen Carlucci Keine Organisationseinheit angegeben Magnifier